Treatment of isolated pediatric optic nerve glioma: A nationwide retrospective cohort study and systematic literature review on visual and radiological outcome
Pediatric Blood & Cancer · 2024
DOI: 10.1002/pbc.31358 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Pediatric Blood & Cancer, 2024. Verfasst von Carlien A Bennebroek und 11 weiteren Autor:innen. Beteiligte Einrichtung: Orbital Center, Department of Ophthalmology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Optic Nerve Glioma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ODAS Foundation, ODAS Stichting.
Abstract (Originalsprache)
Background
Progressive isolated optic nerve glioma (ONG) in children is a rare disease, treated with various modalities. A global treatment consensus is not available.
Methods
We conducted a national retrospective multicenter cohort study (1995–2020) to investigate how different treatment strategies impact outcome for ONG in children, by assessing treatment responses to systemic anticancer therapy (SAT), surgery, and radiotherapy for ONG. The primary endpoints included changes in best‐corrected visual acuity (BCVA) and tumor volume (TV) on MRI, both evaluated at the start and end of therapy and at long‐term follow up.
Results
A total of 21 ONGs (20 patients) received SAT ( n = 14 (66.7%)), surgery ( n = 4 (19.0%)), and radiotherapy ( n = 3 (14.3%)). After SAT BCVA stabilized or improved in 66.6% ( n = 4) and the TV decreased by a median of 45.1% (range: −88.6% to +31.5%) ( n = 13). Before resection two eyes were already blind. After resection BCVA decreased to blindness in one eye. In total all four eyes were blind after resection. After first‐line RT BCVA decreased in 66.7% of ONG to counting fingers or less, TV increased
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Orbital Center, Department of Ophthalmology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
- Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, The Netherlands.
- Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
- Department of Pediatrics, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands.
- ENCORE-NF1 Center, Department of General Pediatrics, Erasmus MC, Rotterdam, The Netherlands.
- Department of Ophthalmology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
ORCID-Profile: Carlien A Bennebroek
Förderung
- ODAS Foundation
- ODAS Stichting
Zitieren
APA
Bennebroek, C. A., Montauban van Swijndregt, M. C., van Zwol, J., Bhusal, S., Dittrich, A. T., Oostenbrink, R., Pott, J. W. R., Buijs, E. A., Schouten-van Meeteren, A. Y., Porro, G. L., de Graaf, P., & Saeed, P. (2024). Treatment of isolated pediatric optic nerve glioma: A nationwide retrospective cohort study and systematic literature review on visual and radiological outcome. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31358
Vancouver
Bennebroek CA, Montauban van Swijndregt MC, van Zwol J, Bhusal S, Dittrich AT, Oostenbrink R, et al. Treatment of isolated pediatric optic nerve glioma: A nationwide retrospective cohort study and systematic literature review on visual and radiological outcome. Pediatric Blood & Cancer. 2024. doi:10.1002/pbc.31358
BibTeX
@article{Bennebroek2024,
author = {Bennebroek, Carlien A and Montauban van Swijndregt, Maartje C and van Zwol, Judith and Bhusal, Sanjhana and Dittrich, Anne T and Oostenbrink, Rianne and Pott, Jan Willem R and Buijs, Erik A and Schouten-van Meeteren, Antoinette Y and Porro, Giorgio L and de Graaf, Pim and Saeed, Peerooz},
title = {Treatment of isolated pediatric optic nerve glioma: A nationwide retrospective cohort study and systematic literature review on visual and radiological outcome},
journal = {Pediatric Blood & Cancer},
year = {2024},
doi = {10.1002/pbc.31358}
}
EUVIMED